Preclinical pharmaceutical development demands a robust understanding of how a compound behaves within the body. This includes analyzing its absorption, distribution, metabolism, and excretion (ADME) properties. Preclinical DMPK services provide essential data to enhance drug candidates during the early stages of development, ultimately expediting